117 related articles for article (PubMed ID: 7379211)
21. Alkylation by dehydroretronecine, a cytotoxic metabolite of some pyrrolizidine alkaloids: an in vitro test.
Mattocks AR; Bird I
Toxicol Lett; 1983 Apr; 16(1-2):1-8. PubMed ID: 6836605
[TBL] [Abstract][Full Text] [Related]
22. Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline.
Glowaz SL; Michnika M; Huxtable RJ
Toxicol Appl Pharmacol; 1992 Aug; 115(2):168-73. PubMed ID: 1641851
[TBL] [Abstract][Full Text] [Related]
23. The effect of monocrotaline, a pyrrolizidine alkaloid, on HeLa cells and primary cultured cells from rat liver and lung.
Umeda M; Saito M
Acta Pathol Jpn; 1971 Nov; 21(4):507-14. PubMed ID: 5172670
[No Abstract] [Full Text] [Related]
24. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
Yan J; Xia Q; Chou MW; Fu PP
Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
[TBL] [Abstract][Full Text] [Related]
25. Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver.
Mattocks AR; Legg RF; Jukes R
Toxicol Lett; 1990 Nov; 54(1):93-9. PubMed ID: 2244344
[TBL] [Abstract][Full Text] [Related]
26. Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline.
Robertson KA
Cancer Res; 1982 Jan; 42(1):8-14. PubMed ID: 6797726
[TBL] [Abstract][Full Text] [Related]
27. Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione.
Robertson KA; Seymour JL; Hsia MT; Allen JR
Cancer Res; 1977 Sep; 37(9):3141-4. PubMed ID: 884667
[TBL] [Abstract][Full Text] [Related]
28. Neoplasia and chronic disease associated with the prolonged administration of dehydroheliotridine to rats.
Peterson JE; Jago MV; Reddy JK; Jarrett RG
J Natl Cancer Inst; 1983 Feb; 70(2):381-6. PubMed ID: 6571945
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and toxicity of synthetic analogues of macrocyclic diester pyrrolizidine alkaloids.
Mattocks AR; Driver HE; Barbour RH; Robins DJ
Chem Biol Interact; 1986 Apr; 58(1):95-108. PubMed ID: 3708724
[TBL] [Abstract][Full Text] [Related]
30. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
Xia Q; He X; Ma L; Chen S; Fu PP
Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181
[TBL] [Abstract][Full Text] [Related]
31. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
Xia Q; Yan J; Chou MW; Fu PP
Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
[TBL] [Abstract][Full Text] [Related]
32. Structural influences on pyrrolizidine alkaloid-induced cytopathology.
Kim HY; Stermitz FR; Molyneux RJ; Wilson DW; Taylor D; Coulombe RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):61-9. PubMed ID: 8378933
[TBL] [Abstract][Full Text] [Related]
33. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
Yan CC; Huxtable RJ
Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
[TBL] [Abstract][Full Text] [Related]
34. The ability of bifunctional and monofunctional pyrrole compounds to induce sister-chromatid exchange (SCE) in human lymphocytes and mutations in Salmonella typhimurium.
Ord MJ; Herbert A; Mattocks AR
Mutat Res; 1985 May; 149(3):485-93. PubMed ID: 3887149
[TBL] [Abstract][Full Text] [Related]
35. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.
Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW
Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054
[TBL] [Abstract][Full Text] [Related]
36. Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine.
Shumaker RC; Robertson KA; Hsu IC; Allen JR
J Natl Cancer Inst; 1976 Apr; 56(4):787-90. PubMed ID: 176409
[TBL] [Abstract][Full Text] [Related]
37. ¹H NMR study of monocrotaline and its metabolites in human blood.
Yang YC; Crowder J; Wardle NJ; Yang L; White KN; Wang ZT; Annie Bligh SW
Food Chem Toxicol; 2011 Nov; 49(11):2793-9. PubMed ID: 21843583
[TBL] [Abstract][Full Text] [Related]
38. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
Mattocks AR; Bird I
Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
[TBL] [Abstract][Full Text] [Related]
39. Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid.
Lin G; Cui YY; Hawes EM
Drug Metab Dispos; 2000 Dec; 28(12):1475-83. PubMed ID: 11095586
[TBL] [Abstract][Full Text] [Related]
40. Identification and toxicological effects of dehydroretronecine, a metabolite of monocrotaline.
Hsu IC; Allen JR; Chesney CF
Proc Soc Exp Biol Med; 1973 Dec; 144(3):834-8. PubMed ID: 4543621
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
